The court may or may not decide to certify the case as a class action depending on the criteria
In summer 2022, Lilly released tirzepatides spectacular Phase III trial results that showed a category-leading 22% weight loss with low side effect burden
It is expected that tirzepatide will occupy a greater percentage of GIPR than GLP1R (4.1, 4.6, and 6.3 fold, respectively, at 15, 10, and 5 mg) [16]
If you take one of these drugs, your doctor may lower your dose when starting Wegovy
Aim for at least 8-10 glasses of water daily, and increase intake if you exercise regularly or live in a dry climate
Nirupama December 25, 2025, 2:43pm 3 Usage of GLP-1 drugs in treating diabetes and obesity is greatly transformative, however lifestyle interventions provide you a total well-being in the long run